Related references
Note: Only part of the references are listed.Protection by cilostazol against amyloid-β1-40-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells
Hye Rin Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction
Salvatore Fusco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation
Sun Haeng Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability
Lilia G. Noriega et al.
EMBO REPORTS (2011)
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Todd J. Cohen et al.
NATURE COMMUNICATIONS (2011)
Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice
Masayuki Hiramatsu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
Erin M. Bowers et al.
CHEMISTRY & BIOLOGY (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Carl Julien et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Therapeutic role of sirtuins in neurodegenerative disease
Tiago Fleming Outeiro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors
Mario A. Pagano et al.
CHEMBIOCHEM (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Neuronal protection by sirtuins in Alzheimer's disease
TS Anekonda et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease
WL Klein et al.
NEUROBIOLOGY OF AGING (2004)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
T Araki et al.
SCIENCE (2004)
The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation
A Jämsä et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Repeat motifs of tau bind to the insides of microtubules in the absence of taxol
S Kar et al.
EMBO JOURNAL (2003)
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation:: Reversibility by drugs that enhance cAMP signaling
OV Vitolo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Disruption of CREB function in brain leads to neurodegeneration
T Mantamadiotis et al.
NATURE GENETICS (2002)
First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
A Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
